Sinofn Health
Sinofn Health
SINOFN Health Co., Ltd. represents the synthesis of advanced biotechnology and large-scale manufacturing. Founded on the bedrock of the Chinese Academy of Sciences' research, we bridge the gap between complex laboratory discovery and commercial viability. Our operational mandate since 2012 has been to transform "Nutritional Science" into "Accessible Global Health."
In the contemporary global nutraceutical market, brands face a dual challenge: meeting rigorous compliance standards and keeping pace with rapidly evolving consumer preferences for bio-available, science-backed ingredients. Our factory model provides a vertical integration solution—from raw material sourcing (like our proprietary Jujube/Tremella extraction) to final shelf-ready packaging.
Our R&D methodology is not merely reactive; it is proactive. Led by Dr. Tan Shengjie (Peking University) and supported by international experts like Hans van Dijk, we operate a 3-tier R&D pipeline: 1. **Bio-Active Discovery** (Molecular level validation), 2. **Formulation Engineering** (Stability and dissolution focus), and 3. **Industrial Scaling** (GMP-standardized production). This ensures that a formula developed in the lab performs identically at the 500-million-unit scale.
Mrs. GuoHong Liu established SINOFN with a mission that transcends profitability: the democratization of high-quality nutrition, particularly for those with specialized medical needs like Phenylketonuria (PKU). This "Profit with Purpose" philosophy dictates our operational standards—every product leaving our factory is treated with the same clinical rigor required for specialized medical foods.
The global supplement market is fractured by varying regulatory frameworks (FDA, EFSA, NMPA, HALAL). SINOFN provides "Regulatory-Ready" manufacturing. Our quality control architecture is ISO 22000, HACCP, and FSSC 22000 certified, ensuring that your products are not only effective but legally compliant for entry into diverse international markets. We handle the complexities of batch tracking, stability testing, and contaminant screening so that your brand can focus on market expansion.
Q: Can you support R&D and rapid prototyping for startups?
A: Yes. We operate a specialized pilot-scale prototyping line designed for agile iteration, allowing new brands to test formulas before full-scale commercialization.
Q: How do you ensure ingredient bio-availability?
A: We utilize advanced HPLC and GC-MS contaminant screening, alongside bioavailability optimization studies performed in our specialized chambers to ensure the active compounds remain stable.
Q: What defines your factory's production capacity?
A: With 10+ dedicated lines for softgels, gummies, and powders, we maintain an annual capacity exceeding 500 million units, ensuring scalability for both SME and enterprise-level partners.
